等待开盘 04-01 09:30:00 美东时间
0.000
0.00%
CytomX Therapeutics, Inc. will announce its 2025 full-year financial results on March 16, 2026, before U.S. markets open. A conference call and webcast will follow at 8:00 a.m. ET / 5:00 a.m. PT. Participants can access the webcast via CytomX’s website and register in advance. CytomX, focused on developing conditionally activated biologics, is a clinical-stage oncology company advancing novel therapeutics targeting the tumor microenvironment. The...
03-04 13:00
ImageneBio授予了新任CEO Kristin Yarema 436,080股股票期权和153,505股限制性股票单位,作为其加入公司的激励。这些奖项包括四年归属期和基于 Nasdaq规则的条件。ImageneBio专注于免疫和炎症疾病治疗的开发。
2025-08-01 20:15
Adds details on other board members in paragraph 3 By Svea Herbst-Bayliss BEVERLY HILLS, May 7 (Reuters) - Pharmaceutical company Charles River Laboratories CRL.N has reached a settlement with activis...
2025-05-07 22:10
Adds background in paragraphs 2, 3; details throughout April 3 (Reuters) - AbbVie ABBV.N on Thursday cut its 2025 adjusted profit forecast as the drugmaker expects to incur $248 million in acquisition...
2025-04-04 04:48
港府下周三(26日)將發表新一年度《財政預算案》,據《星島日報》報道,在訪問多名教育界人士及立法會議員後,推測除了削減資助大學撥款外,現時毋須審查、為全港近8...
2025-02-21 12:36
Adds background on Bristol Myers' drug in paragraphs 7 and 8 and details on other Cerevel-related assets in paragraph 9 Jan 10 (Reuters) - Abbvie ABBV.N said on Friday it would record a charge of abou...
2025-01-10 21:53
Adds details throughout, background in paragraphs 2-3 Jan 6 (Reuters) - AbbVie ABBV.N lowered its 2024 adjusted profit forecast on Monday as the drugmaker incurred $1.6 billion in acquisition expenses...
2025-01-07 05:40
自2022年下半年以来,FRα ADC(叶酸受体α抗体药物偶联物)领域的好消息,接踵而至。 当年11月15日,Immunogen公司长期研发的FRα ADC药物...
2024-07-02 07:28